Back to search
FDAFDA · Food and drugs·Recall number D-1016-2016

TRI-MIX # 1, packaged in 5mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121

Published June 15, 2016 · Recall initiated: May 17, 2016

Summary

FDA records drug Class II recall D-1016-2016, published June 15, 2016 and initiated May 17, 2016. Recalling firm: Well Care Compounding Pharmacy; Status: Terminated; Reported quantity: 869 Units (Total All Products); Lot: Lot #: 02292016:67@10, Exp. 05/29/2016; Lot #: 03022016: 98@43, Exp.05/31/2016; Lot #: 03162016:25@32, Exp. 06/14/2016; Lot #: 03302016:36@36, Exp.06/30/2016. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Well Care Compounding Pharmacy
Distributor
NV
Lot
Lot #: 02292016:67@10, Exp. 05/29/2016; Lot #: 03022016: 98@43, Exp.05/31/2016; Lot #: 03162016:25@32, Exp. 06/14/2016; Lot #: 03302016:36@36, Exp.06/30/2016
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was TRI-MIX # 1, packaged in 5mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121 recalled?

Yes. FDA published recall D-1016-2016 on June 15, 2016. Reported hazard: Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release